Clinical trial

The Differential Effects of Diabetes Therapy on Inflammation

NCT02150707

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2014-05-01

PhaseN/A

Study timeline

Study start (unknown)2014-05-01Date precision: month

Registry last updated2016-05-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Nephropathyunresolved

Type 2 Diabetesunresolved

Interventions

Dipeptidyl-Peptidase IV InhibitorsDRUG

Glucagon-Like Peptide 1DRUG

Sponsors & collaborators

University College Dublinlead sponsor

Irish Endocrine Societycollaborator

Royal College of Physicianscollaborator

Merck Sharp & Dohme LLCcollaborator

Eli Lilly and Companycollaborator

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02150707 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.